BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3028398)

  • 21. Development of new potent and selective agents against HIV (human immunodeficiency virus).
    Pauwels R; Schols D
    Verh K Acad Geneeskd Belg; 1991; 53(6):629-55. PubMed ID: 1816706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
    Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
    Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS-associated neurological disorders.
    Palomino E; Meltsner BR; Kessel D; Horwitz JP
    J Med Chem; 1990 Jan; 33(1):258-63. PubMed ID: 2153206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.
    Vogt MW; Durno AG; Chou TC; Coleman LA; Paradis TJ; Schooley RT; Kaplan JC; Hirsch MS
    J Infect Dis; 1988 Aug; 158(2):378-85. PubMed ID: 2841378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
    Balzarini J; Van Aerschot A; Pauwels R; Baba M; Schols D; Herdewijn P; De Clercq E
    Mol Pharmacol; 1989 May; 35(5):571-7. PubMed ID: 2725468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
    J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiretroviral and cytostatic activity, and metabolism of 3'-azido-2',3'-dideoxythymidine, 3'-fluoro-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly cell type-dependent.
    Balzarini J; Matthes E; Meeus P; Johns DG; De Clercq E
    Adv Exp Med Biol; 1989; 253B():407-13. PubMed ID: 2558542
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro.
    Baba M; Ito M; Shigeta S; Tanaka H; Miyasaka T; Ubasawa M; Umezu K; Walker RT; De Clercq E
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1430-3. PubMed ID: 1929304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
    Pauwels R; Andries K; Desmyter J; Schols D; Kukla MJ; Breslin HJ; Raeymaeckers A; Van Gelder J; Woestenborghs R; Heykants J
    Nature; 1990 Feb; 343(6257):470-4. PubMed ID: 1689015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 2',3'-dideoxynucleosides on mammalian cells and viruses.
    Waqar MA; Evans MJ; Manly KF; Hughes RG; Huberman JA
    J Cell Physiol; 1984 Nov; 121(2):402-8. PubMed ID: 6092393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors.
    Hayashi S; Fine RL; Chou TC; Currens MJ; Broder S; Mitsuya H
    Antimicrob Agents Chemother; 1990 Jan; 34(1):82-8. PubMed ID: 1691616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
    Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
    Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.
    McGrath MS; Hwang KM; Caldwell SE; Gaston I; Luk KC; Wu P; Ng VL; Crowe S; Daniels J; Marsh J
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2844-8. PubMed ID: 2704750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species.
    Balzarini J; Pauwels R; Baba M; Herdewijn P; de Clercq E; Broder S; Johns DG
    Biochem Pharmacol; 1988 Mar; 37(5):897-903. PubMed ID: 2830886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of 3'-azido-2',3'-dideoxythymidine on experimental viral infections].
    Shneĭder MA; Rudenko NK; Kavsan VM; Bibilashvili RSh; Kraevskiĭ AA
    Mol Biol (Mosk); 1987; 21(3):837-46. PubMed ID: 2821379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
    Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
    Balzarini J; Pauwels R; Baba M; Robins MJ; Zou RM; Herdewijn P; De Clercq E
    Biochem Biophys Res Commun; 1987 May; 145(1):269-76. PubMed ID: 3496089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.